CHD5 and glioma: The results showed that the expression of CHD5 was significantly positively correlated with the age in three tumor types, namely, Glioma (p = 0.02), KIRC (p = 0.03), and UCS (p = 0.03), and was significantly negatively correlated in MESO (p = 0.01) (Figure 3A).